Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1788963 | 0.82 | PAX8 (0.41) | PAX8USP2SLCO1B1 | |
| SCHEMBL17767377 | 0.82 | PAX8 (0.41) | PAX8USP2SLCO1B1 | |
| SCHEMBL736616 | 0.81 | USP2 (0.39) | PAX8USP2SLCO1B1PTGS1SLC7A11 | |
| SCHEMBL2159143 | 0.80 | PAX8 (0.34) | PAX8 | |
| SCHEMBL8038751 | 0.80 | PAX8 (0.39) | PAX8 | |
| SCHEMBL9807660 | 0.80 | USP2 (0.43) | PAX8USP2SLCO1B1 | |
| SCHEMBL9807657 | 0.80 | USP2 (0.43) | PAX8USP2SLCO1B1 | |
| SCHEMBL9617278 | 0.78 | PAX8 (0.40) | PAX8USP2SLCO1B1 | |
| SCHEMBL2223103 | 0.78 | PAX8 (0.40) | PAX8USP2SLCO1B1 | |
| SCHEMBL16429713 | 0.78 | USP2 (0.38) | PAX8USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150023941-A1 | Compositions Comprising Sugar-Cysteine Products | EAST WEST BANK | 2015-01-22 | — | — | US | disclosed |
| US-20140348811-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2014-11-27 | — | — | US | disclosed |
| US-8853170-B2 | Compositions comprising sugar-cysteine products | MAX INTERNATIONAL, LLC (US) | 2014-10-07 | — | — | US | disclosed |
| WO-2013016636-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2013-01-31 | — | — | WO | disclosed |
| WO-2011149835-A1 | COMPOSITIONS AND BEVERAGES COMPRISING NUTRIENTS, VITAMINS, SUGARS, CYSTEINE, AND/OR SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20110287109-A1 | Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products | MAX INTERNATIONAL, LLC (US) | 2011-11-24 | — | — | US | disclosed |
| WO-2011094491-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011094490-A1 | METHODS OF PREPARING THIAZOLIDINES | MAX INTERNATIONAL, LLC (US) | 2011-08-04 | — | — | WO | disclosed |
| US-20110183927-A1 | Compositions Comprising Sugar-Cysteine Products | MAX INTERNATIONAL, LLC (US) | 2011-07-28 | — | — | US | disclosed |
| US-20110184185-A1 | Methods Of Preparing Thiazolidines | MAX INTERNATIONAL, LLC (US) | 2011-07-28 | — | — | US | disclosed |
| WO-2010133975-A2 | REDUCIBLE POLYAMINO DISULFIDES AS TRANSFECTANTS | IMUTHES LIMITED (GB) | 2010-11-25 | — | — | WO | disclosed |
| US-20080200563-A1 | Use of Compounds Containing Thiol Groups as Efflux Pump Inhibitors | THIOMATRIX FORSCHUNGS- UND BERATUNGS- GMBH (AT) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184185-A1 | Methods Of Preparing Thiazolidines | RPIA, DPYD, TXN | PAX8 2269/4885USP2 2626/4885SLCO1B1 734/4885 |
| US-20150023941-A1 | Compositions Comprising Sugar-Cysteine Products | CBS, CTH, GCLC | PAX8 3570/4885USP2 586/4885SLCO1B1 455/4885 |
| US-20140348811-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | CBS, CTH, GCLC | PAX8 3570/4885USP2 586/4885SLCO1B1 455/4885 |
| US-20110183927-A1 | Compositions Comprising Sugar-Cysteine Products | CBS, CTH, GCLC | PAX8 3570/4885USP2 586/4885SLCO1B1 455/4885 |
| US-20110287109-A1 | Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products | CBS, PROC, SLC7A11 | PAX8 3426/4885USP2 2067/4885SLCO1B1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.